Hereditary spastic paraplegia: from decades of therapy to future innovations. [PDF]
Cipriano L +2 more
europepmc +1 more source
Mathematical Comments on Linking Neurofilament Light Chain Levels to Disease Severity in Hereditary Spastic Paraplegia Subtypes SPG11 and SPG15. [PDF]
Fischer G.
europepmc +1 more source
Macular Dystrophy Associated With Hereditary Spastic Paraplegia Type 11 (Kjellin Syndrome): A Multidisciplinary Case Report. [PDF]
Grech M +4 more
europepmc +1 more source
Botulinum Toxin Treatment in Hereditary Spastic Paraplegia-A Comprehensive Review and Update. [PDF]
Jabbari B, Comtesse S, Tavassoli F.
europepmc +1 more source
Loss-of-Function Variants in CPT1C: No Support for a Causal Role in Hereditary Spastic Paraplegia. [PDF]
Zhu R +17 more
europepmc +1 more source
Early-onset hereditary spastic paraplegia type 56 (SPG56): clinical-molecular correlations and functional validation of CYP2U1 variants. [PDF]
Sustrova E +13 more
europepmc +1 more source
Selective Dorsal Rhizotomy in Children with Hereditary Spastic Paraplegia.
Stanton AN +8 more
europepmc +1 more source
Children with suspected hereditary spastic paraplegia clearly benefit from whole exome analysis. [PDF]
Safka Brozkova D +7 more
europepmc +1 more source
Reply to: Mathematical Comments on Linking Neurofilament Light Chain Levels to Disease Severity in Hereditary Spastic Paraplegia Subtypes SPG11 and SPG15. [PDF]
Agianda HAP, Ebrahimi-Fakhari D.
europepmc +1 more source

